Brief: Phaseone Health And Novabay Pharmaceuticals To Expand Commercial And Collaborative Strategies For The Wound Care Market
17/01/2023 12:08
Jan 17 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* PHASEONE HEALTH AND NOVABAY PHARMACEUTICALS TO EXPAND
COMMERCIAL
AND COLLABORATIVE STRATEGIES FOR THE WOUND CARE MARKET
Source text for Eikon: ID:nBw4B0w4Ja
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing